Atlas Trials

Allogenic Haematopoietic Cell Transplantation for Patients With Refractory "Triple Negative" Breast Cancer

Clinical trial NCT01375023 · TERMINATED

Trial details

NCT number
NCT01375023
Sponsor
European Institute of Oncology
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2009-06-01
Primary completion
2013-07-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.